معرفی
Dong H. Kwon is a Professor of Biology at Long Island University (LIU), within the College of Liberal Arts and Sciences. His academic journey includes a Ph.D. from Georgia State University and a postdoctoral fellowship at Baylor College of Medicine. His research is deeply rooted in pharmaceutical biotechnology and molecular microbiology, with a focus on antimicrobial resistance mechanisms and novel therapeutic strategies against multidrug-resistant bacterial pathogens.
Education:
- Ph.D., Georgia State University
- Post-Doc, Baylor College of Medicine
Research Focus:
Professor Kwon’s research has evolved from studying Helicobacter pylori to tackling multidrug-resistant Gram-negative pathogens such as Acinetobacter baumannii, Klebsiella pneumoniae, and Pseudomonas aeruginosa. His work emphasizes:
- Molecular mechanisms of antibiotic resistance
- Natural compounds to restore antibiotic susceptibility
- Redox homeostasis disruption in bacteria
- Next-generation sequencing for resistance profiling
- Efflux pump inhibition and membrane modification
Scientific Contributions & Trends:
His publications reflect a consistent trajectory in antibiotic resistance genomics, natural compound synergism, and clinical microbiology. Notably, his work on Helicobacter pylori has provided critical insights into clarithromycin and metronidazole resistance, while his recent studies on Acinetobacter baumannii and Pseudomonas aeruginosa explore glutathione-mediated redox control and polyphenol-based adjuvant therapies.
Awards & Honors:
- Young Scientist Award – Xth International Workshop on Gastroduodenal Pathology and Helicobacter pylori
- Best Paper Award – Third Annual Winter H. pylori Workshop
- First Prize – 5th Annual Meeting of the Japanese Society for Helicobacter Research
- NIH Research Grant
- U.S. Patent No. 11/420,671: "Use of Polyamines with Antibiotics"
Professional Affiliations:
- Member, American Society for Microbiology
- Member, American Gastroenterology Association
Laboratory & Research Environment:
Professor Kwon operates within a microbiology-focused research environment at LIU, where he leads projects involving molecular genetics, antimicrobial susceptibility testing, and natural product-based therapeutic development. His lab is engaged in both basic science and translational research, aiming to bridge the gap between bench discoveries and clinical applications in infectious disease treatment.
